Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 17, 2021
Total Value: $381M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| POLWQ | 1847 GOEDEKER INC | 6,886,600 | $11.57M | 3.0% | $2.14 | — | *W EXP 99/99/999 | 28252C117 |
| — | BELLUS HEALTH INC NEW | 1,788,789 | $10.98M | 2.9% | $3.07 | — | COM NEW | 07987C204 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 185,000 | $9.988M | 2.6% | $34.82 | +34.8% | COM NEW | 15117B202 |
| — | CTI BIOPHARMA CORP | 3,313,000 | $9.773M | 2.6% | $2.62 | — | COM | 12648L601 |
| ALDX | ALDEYRA THERAPEUTICS INC | 864,020 | $7.586M | 2.0% | $11.70 | -21.6% | COM | 01438T106 |
| LNTH | LANTHEUS HLDGS INC | 290,000 | $7.447M | 2.0% | $15.53 | +68.3% | COM | 516544103 |
| XTNT | XTANT MED HLDGS INC | 6,254,458 | $6.942M | 1.8% | $1.78 | -26.9% | COM NEW | 98420P308 |
| — | VERASTEM INC | 2,253,000 | $6.939M | 1.8% | $2.36 | — | COM | 92337C104 |
| CERS | CERUS CORP | 1,100,000 | $6.699M | 1.8% | $5.85 | -0.4% | COM | 157085101 |
| — | CURIS INC | 829,000 | $6.491M | 1.7% | $8.18 | — | COM NEW | 231269200 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,233,642 | $6.279M | 1.6% | $6.93 | -22.8% | COM | 23284F105 |
| IMTX | IMMATICS N.V | 478,987 | $6.227M | 1.6% | $11.15 | +14.0% | SHS | N44445109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 346,000 | $6.131M | 1.6% | $27.44 | +55.4% | COM | 74366E102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 255,000 | $6.092M | 1.6% | $27.37 | -16.7% | COM | 03969K108 |
| INSP | INSPIRE MED SYS INC | 26,000 | $6.055M | 1.6% | $200.46 | +4.1% | COM | 457730109 |
| — | NEVRO CORP | 51,000 | $5.935M | 1.6% | $128.57 | — | COM | 64157F103 |
| — | CHINOOK THERAPEUTICS INC | 465,000 | $5.933M | 1.6% | $14.75 | — | COM | 16961L106 |
| CDNA | CAREDX INC | 90,000 | $5.703M | 1.5% | $77.20 | -1.4% | COM | 14167L103 |
| — | SYROS PHARMACEUTICALS INC | 1,272,412 | $5.688M | 1.5% | $5.50 | — | COM | 87184Q107 |
| INSM | INSMED INC | 203,354 | $5.6M | 1.5% | $33.39 | -21.4% | COM PAR $.01 | 457669307 |
| OCUL | OCULAR THERAPEUTIX INC | 556,000 | $5.56M | 1.5% | $13.04 | -13.9% | COM | 67576A100 |
| RNAM | AVIDITY BIOSCIENCES INC | 225,000 | $5.542M | 1.5% | $23.98 | -9.4% | COM | 05370A108 |
| APLS | APELLIS PHARMACEUTICALS INC | 166,700 | $5.494M | 1.4% | — | — | Put | 03753U106 |
| — | KALEYRA INC | 484,592 | $5.335M | 1.4% | $12.24 | — | COM | 483379103 |
| — | IVERIC BIO INC | 328,101 | $5.328M | 1.4% | $6.91 | — | COM | 46583P102 |
| HAE | HAEMONETICS CORP MASS | 74,000 | $5.224M | 1.4% | $77.08 | -18.1% | COM | 405024100 |
| MYGN | MYRIAD GENETICS INC | 158,000 | $5.102M | 1.3% | $16.15 | +105.6% | COM | 62855J104 |
| NTRA | NATERA INC | 45,500 | $5.071M | 1.3% | $105.62 | +8.5% | COM | 632307104 |
| — | MEI PHARMA INC | 1,828,066 | $5.045M | 1.3% | $3.05 | — | COM NEW | 55279B202 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $4.99M | 1.3% | $9.86 | — | ORDINARY SHARES | G6580S114 |
| KROS | KEROS THERAPEUTICS INC | 126,000 | $4.985M | 1.3% | $35.59 | 0.0% | COM | 492327101 |
| — | AEGLEA BIOTHERAPEUTICS INC | 609,689 | $4.847M | 1.3% | $7.36 | — | COM | 00773J103 |
| CSTL | CASTLE BIOSCIENCES INC | 72,500 | $4.821M | 1.3% | $61.79 | +13.9% | COM | 14843C105 |
| VREX | VAREX IMAGING CORP | 158,000 | $4.456M | 1.2% | $22.78 | +21.7% | COM | 92214X106 |
| — | AVADEL PHARMACEUTICALS PLC | 440,589 | $4.318M | 1.1% | $6.68 | — | SPONSORED ADR | 05337M104 |
| — | X4 PHARMACEUTICALS INC | 804,598 | $4.256M | 1.1% | $5.29 | — | COM | 98420X103 |
| — | AFFIMED N V | 665,000 | $4.11M | 1.1% | $6.18 | — | COM | N01045108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 193,000 | $4.063M | 1.1% | $15.10 | +38.5% | COM | 22663K107 |
| ILMN | ILLUMINA INC | 10,000 | $4.056M | 1.1% | $347.00 | +32.5% | COM | 452327109 |
| — | EUCRATES BIOMEDICAL ACQU COR | 400,000 | $3.912M | 1.0% | $9.85 | — | SHS | G3141W106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 370,551 | $3.861M | 1.0% | $10.89 | -12.4% | COM NEW | 30233G209 |
| BCYC | BICYCLE THERAPEUTICS PLC | 92,000 | $3.826M | 1.0% | $41.59 | — | SPONSORED ADS | 088786108 |
| ARCT | ARCTURUS THERAPEUTICS HLDGS | 80,000 | $3.822M | 1.0% | $44.81 | 0.0% | COM | 03969T109 |
| BBIO | BRIDGEBIO PHARMA INC | 79,000 | $3.703M | 1.0% | $53.60 | 0.0% | COM | 10806X102 |
| — | RENOVACOR INC | 388,845 | $3.519M | 0.9% | $9.05 | — | COM | 75989E106 |
| PROF | PROFOUND MED CORP | 235,000 | $3.44M | 0.9% | $21.14 | -27.9% | COM NEW | 74319B502 |
| — | ICAD INC | 320,000 | $3.44M | 0.9% | $10.75 | — | COM NEW | 44934S206 |
| TVTX | TRAVERE THERAPEUTICS INC | 141,000 | $3.419M | 0.9% | $26.07 | -29.5% | COM | 89422G107 |
| — | MORPHIC HLDG INC | 60,000 | $3.398M | 0.9% | $61.12 | — | COM | 61775R105 |
| XENE | XENON PHARMACEUTICALS INC | 216,000 | $3.3M | 0.9% | $18.13 | -4.2% | COM | 98420N105 |
| — | VERRICA PHARMACEUTICALS INC | 256,244 | $3.203M | 0.8% | $14.45 | — | COM | 92511W108 |
| AUPH | AURINIA PHARMACEUTICALS INC | 144,000 | $3.187M | 0.8% | $14.54 | +9.1% | COM | 05156V102 |
| — | ADAMAS PHARMACEUTICALS INC | 625,469 | $3.071M | 0.8% | $4.84 | — | COM | 00548A106 |
| — | TRACON PHARMACEUTICALS INC | 785,341 | $3.039M | 0.8% | $3.87 | — | COM NEW | 89237H209 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,250,000 | $3.025M | 0.8% | $3.37 | — | ADS | 589492107 |
| GMED | GLOBUS MED INC | 38,500 | $2.95M | 0.8% | $63.14 | +27.2% | CL A | 379577208 |
| DDI | DOUBLEDOWN INTERACTIVE CO LT | 160,000 | $2.818M | 0.7% | $17.61 | — | ADS | 25862B109 |
| — | IGM BIOSCIENCES INC | 42,473 | $2.793M | 0.7% | $83.21 | — | COM | 449585108 |
| KRMD | REPRO MED SYS INC | 954,055 | $2.719M | 0.7% | $3.78 | -12.5% | COM | 759910102 |
| DYN | DYNE THERAPEUTICS INC | 166,636 | $2.706M | 0.7% | $19.35 | -8.4% | COM | 26818M108 |
| FLUX | FLUX PWR HLDGS INC | 521,972 | $2.652M | 0.7% | $8.45 | 0.0% | COM NEW | 344057302 |
| CELC | CELCUITY INC | 145,000 | $2.61M | 0.7% | $25.73 | -17.6% | COM | 15102K100 |
| MLTX | HELIX ACQUISITION CORP | 250,000 | $2.488M | 0.7% | $11.37 | — | COM CL A | G4444C102 |
| — | TURMERIC ACQUISITION CORP | 254,000 | $2.487M | 0.7% | $9.89 | — | CL A | G9127T108 |
| GRTX | GALERA THERAPEUTICS INC | 300,605 | $2.435M | 0.6% | $8.25 | +4.0% | COM | 36338D108 |
| — | PHASEBIO PHARMACEUTICALS INC | 775,000 | $2.41M | 0.6% | $3.46 | — | COM | 717224109 |
| CRDF | CARDIFF ONCOLOGY INC | 348,888 | $2.324M | 0.6% | $8.48 | -25.9% | COM | 14147L108 |
| — | SARISSA CAPITAL ACQUISITN CO | 225,000 | $2.219M | 0.6% | $9.86 | — | CL A | G7823W102 |
| VQSSF | VIQ SOLUTIONS INC | 704,687 | $2.086M | 0.5% | $5.22 | 0.0% | COM NEW | 91825V400 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 108,000 | $2.064M | 0.5% | $16.66 | 0.0% | COM | 87164F105 |
| — | YUMANITY THERAPEUTICS INC | 196,000 | $2.023M | 0.5% | $14.73 | — | COM | 98872L102 |
| — | FS DEVELOPMENT CORP II | 200,000 | $1.99M | 0.5% | $9.96 | — | COM CL A | 30318F100 |
| HYPR | HEALTHCOR CATALIO ACQU CORP | 200,000 | $1.98M | 0.5% | $10.00 | — | CL A SHS | G44125105 |
| — | GIGINTERNATIONAL1 INC | 200,000 | $1.974M | 0.5% | $9.87 | — | COM | 37518W106 |
| — | CHAVANT CAPITAL ACQUISITN CO | 200,000 | $1.97M | 0.5% | $9.85 | — | ORDINARY SHARES | G2058L103 |
| — | LAKESHORE ACQUISITION I CORP | 200,000 | $1.966M | 0.5% | $9.83 | — | ORDINARY SHARES | G53521103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 111,834 | $1.952M | 0.5% | $26.28 | -22.9% | COM | 483497103 |
| — | JIYA ACQUISITION CORP | 200,000 | $1.95M | 0.5% | $10.30 | — | COM CL A | 47760M102 |
| — | ELOXX PHARMACEUTICALS INC | 1,118,000 | $1.822M | 0.5% | $1.85 | — | COM | 29014R103 |
| — | ONCORUS INC | 192,054 | $1.794M | 0.5% | $9.34 | — | COM | 68236R103 |
| LFMD | LIFEMD INC | 288,700 | $1.793M | 0.5% | $8.53 | 0.0% | COM | 53216B104 |
| — | CHIMERIX INC | 281,790 | $1.744M | 0.5% | $6.19 | — | COM | 16934W106 |
| — | VINCERX PHARMA INC | 107,625 | $1.74M | 0.5% | $12.99 | — | COM NEW | 92731L106 |
| HLMN | HILLMAN SOLUTIONS CORP | 142,000 | $1.694M | 0.4% | $12.24 | 0.0% | COM | 431636109 |
| ATON | PORTAGE BIOTECH INC | 75,000 | $1.524M | 0.4% | $591.48 | -36.2% | COM | G7185A128 |
| — | EIGER BIOPHARMACEUTICALS INC | 197,500 | $1.319M | 0.3% | $12.29 | — | COM | 28249U105 |
| — | VIRPAX PHARMACEUTICALS INC | 271,846 | $1.305M | 0.3% | $4.80 | — | COM | 928251107 |
| — | FAT BRANDS INC | 227,000 | $1.297M | 0.3% | $2.70 | — | *W EXP 07/16/202 | 30258N121 |
| — | TAILWIND ACQUISITION CORP | 128,414 | $1.256M | 0.3% | $9.92 | — | COM CL A | 87403Q102 |
| PODD | INSULET CORP | 4,250 | $1.208M | 0.3% | $252.60 | +12.9% | COM | 45784P101 |
| — | ADICET BIO INC | 142,289 | $1.116M | 0.3% | $13.08 | — | COM | 007002108 |
| — | CITIC CAPITAL ACQUISITION CO | 111,200 | $1.109M | 0.3% | $9.99 | — | COM CL A | G21513109 |
| — | STRYVE FOODS INC | 200,000 | $1.07M | 0.3% | $5.35 | — | CLASS A COM | 863685103 |
| PRQR | PROQR THRAPEUTICS N V | 125,000 | $1.046M | 0.3% | $6.53 | 0.0% | SHS EURO | N71542109 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 122,000 | $1.037M | 0.3% | $9.52 | -17.6% | COM | 004468500 |
| — | MOTIVE CAPITAL CORP | 102,099 | $1.011M | 0.3% | $9.80 | — | SHS CL A | G6293A103 |
| — | ARYA SCIENCES ACQUISITN CORP | 100,000 | $1.005M | 0.3% | $10.05 | — | CLASS A ORD SHS | G31658100 |
| — | BCLS ACQUISITION CORP | 100,000 | $996K | 0.3% | $11.14 | — | COM CL A | G0904B105 |
| — | FIRSTMARK HORIZON ACQUISITIO | 100,000 | $980K | 0.3% | $10.00 | — | CL A COM | 33765Y101 |
| — | OMEGA ALPHA SPAC | 100,000 | $974K | 0.3% | $9.90 | — | CL A | G6749V107 |
| — | ALLENA PHARMACEUTICALS | 1,067,886 | $963K | 0.3% | $0.90 | — | COM | 018119107 |
| — | COLISEUM ACQUISITION CORP | 85,000 | $846K | 0.2% | $9.95 | — | CLASS A ORD SHS | G2263T123 |
| — | CEREVEL THERAPEUTICS HLDNG I | 20,700 | $611K | 0.2% | — | — | Put | 15678U128 |
| — | ALIGOS THERAPEUTICS INC | 33,492 | $519K | 0.1% | $15.50 | — | COM | 01626L105 |
| — | TCR2 THERAPEUTICS INC | 59,150 | $503K | 0.1% | $25.21 | — | COM | 87808K106 |
| — | RENOVACOR INC | 731,561 | $501K | 0.1% | $0.68 | — | *W EXP 99/99/999 | 75989E114 |
| — | COLOMBIER ACQUISITION CORP | 50,000 | $484K | 0.1% | $9.68 | — | CL A | 19533H108 |
| — | IMMATICS N.V | 97,467 | $389K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| SCYX | SCYNEXIS INC | 70,000 | $371K | 0.1% | $6.55 | 0.0% | COM NEW | 811292200 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 600,000 | $351K | 0.1% | $0.63 | — | *W EXP 05/09/202 | 41150T116 |
| KRYS | KRYSTAL BIOTECH INC | 5,800 | $303K | 0.1% | — | — | Call | 501147102 |
| — | POSEIDA THERAPEUTICS INC | 32,238 | $235K | 0.1% | $7.29 | — | COM | 73730P108 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $210K | 0.1% | $0.38 | — | RIGHT 12/26/2025 | G6580S106 |
| — | EUCRATES BIOMEDICAL ACQU COR | 133,333 | $107K | 0.0% | $1.04 | — | *W EXP 10/23/202 | G3141W122 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $99,000 | 0.0% | $12.80 | — | ORD SHS | G4411D109 |
| RSVRW | RESERVOIR MEDIA INC | 50,000 | $99,000 | 0.0% | $1.98 | — | *W EXP 08/26/202 | 76119X113 |
| SRZNW | SURROZEN INC | 82,233 | $94,000 | 0.0% | $1.14 | — | *W EXP 08/01/203 | 86889P117 |
| — | LAKESHORE ACQUISITION I CORP | 150,000 | $79,000 | 0.0% | $0.53 | — | *W EXP 07/15/202 | G53521111 |
| — | SARISSA CAPITAL ACQUISITN CO | 75,000 | $75,000 | 0.0% | $1.00 | — | *W EXP 10/23/202 | G7823W110 |
| — | CHAVANT CAPITAL ACQUISITN CO | 150,000 | $72,000 | 0.0% | $0.48 | — | *W EXP 99/99/999 | G2058L111 |
| — | TURMERIC ACQUISITION CORP | 84,666 | $55,000 | 0.0% | $0.92 | — | *W EXP 10/08/202 | G9127T124 |
| — | GIGINTERNATIONAL1 INC | 50,000 | $37,000 | 0.0% | $0.74 | — | *W EXP 04/19/202 | 37518W114 |
| — | COLOMBIER ACQUISITION CORP | 16,666 | $9,000 | 0.0% | $0.54 | — | *W EXP 99/99/999 | 19533H116 |
| UPHLW | UPHEALTH INC | 10,000 | $5,000 | 0.0% | $0.90 | — | *W EXP 06/08/202 | 91532B119 |